Published in Drug Week, October 1st, 2004
These trials are being conducted under investigational new drug (IND) applications, which were filed by Allergan with the U.S. Food and Drug Administration (FDA) in June.
This milestone marks the start of a comprehensive program of phase I-II studies, which will be conducted in the U.S. and in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.